移植物抗宿主病
耐火材料(行星科学)
寄主(生物学)
医学
疾病
慢性病
重症监护医学
内科学
生物
遗传学
天体生物学
作者
Daniel Wolff,Corey Cutler,Stephanie J. Lee,Iskra Pusic,Henrique Bittencourt,Jennifer White,Mehdi Hamadani,Sally Arai,Amandeep Salhotra,Josè Antonio Pérez-Simón,Amin M. Alousi,Hannah Choe,Mi Kwon,Arancha Bermúdez,Inho Kim,Gèrard Socié,Saurabh Chhabra,Vedran Radojčić,Timothy E. O’Toole,Chuan Tian
标识
DOI:10.1056/nejmoa2401537
摘要
Targeting CSF1R-dependent monocytes and macrophages with axatilimab resulted in a high incidence of response among patients with recurrent or refractory chronic GVHD. (Funded by Syndax Pharmaceuticals and Incyte; AGAVE-201 ClinicalTrials.gov number, NCT04710576.).
科研通智能强力驱动
Strongly Powered by AbleSci AI